In this work, the authors showed that the CD147 is highly expressed in glioma cell lines, and that CD147 increases NRF2 expression by regulating the AKT/GSK3β pathway, inhibiting the βTRCP-mediated degradation of NRF2. Here, NFE2L2 is linked to glioma.